Montana Compounding Pharmacy Recalls Avastin Syringes Due to Sterility Concerns
Montana Compounding Pharmacy is recalling Avastin syringes because FDA inspectors observed objectionable conditions that raise concerns about sterility.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves a lack of assurance of sterility in an injectable medication, which poses a significant risk of serious health consequences such as infection.
Plain-English summary
Montana Compounding Pharmacy is recalling 259 syringes of Avastin, solution, 1.25 mg/0.05mL, Injectable, Syringe, Rx only. The product was distributed in Montana and North Dakota. The recall involves specific lots with expiry dates ranging from May 20, 2015, to June 12, 2015.
The recall was initiated due to a lack of assurance of sterility. This determination was made after objectionable conditions were observed during a U.S. Food and Drug Administration (FDA) inspection. The FDA has classified this recall as Class II.
Patients who have received this medication should contact their healthcare provider for guidance. The FDA advises that patients should not use the recalled product and should return it to the pharmacy or follow the instructions provided by their healthcare professional.
The recalled product
- Product
- Avastin, solution, 1.25 mg/0.05mL, Injectable, Syringe, Rx only, compounded by Montana Compounding Pharmacy, Missoula, MT
- Manufacturer
- Montana Compounding Pharmacy
- Category
- Drug — Injectable Medication
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (8)
- Lot 04202015:49@1
- Expiry date: 5/20/2015
- Lot 04272015:06@6
- Expiry date: 6/2/2015
- Lot 04282015:16@13
- Expiry date: 6/12/2015
- Lot 05062015:56@3
- Expiry date: 5/24/2015
Distribution
Part of a larger recall action
This product is one of 12 recalled by Montana Compounding Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 12 products in this recall →Related recalls
Same manufacturer · Montana Compounding Pharmacy
See all →- SevereMontana Compounding Pharmacy Recalls Trimix Injectable Due to Sterility Concerns
FDA (Drugs) · 2015-06-17
- SevereMontana Compounding Pharmacy Recalls Hyaluronidase Injectable Solution Due to Sterility Concerns
FDA (Drugs) · 2015-06-17
- SevereMontana Compounding Pharmacy Recalls Glutathione Inhalation Solution Due to Sterility Concerns
FDA (Drugs) · 2015-06-17
- SevereMontana Compounding Pharmacy Recalls Glutathione Nasal Solution Due to Sterility Concerns
FDA (Drugs) · 2015-06-17
- SevereMontana Compounding Pharmacy Recalls Alprostadil Injectable Due to Sterility Concerns
FDA (Drugs) · 2015-06-17
Same hazard · sterility
See all →- SevereRegeneron Recalls Libtayo Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-08-26
- SeverePrestige Recalls Clear Eyes Maximum Itchy Eye Relief Due to Sterility Concerns
FDA (Drugs) · 2026-08-19
- SevereROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SevereFDA Recalls ROHTO OPTIC GLOW Eye Drops Over Sterility Concerns
FDA (Drugs) · 2026-07-29